Target Drug Delivery

The Endovab platform for distal guidewire fixation enables a new and patented drug delivery opportunity. By distal fixation of a micro catheter, a drug could be delivered from an external pump directly to a target site while the patient is active, without catheter displacement.
Intra-arterial drug delivery is known to allow for higher local drug concentration while reducing side effects compared to systemic delivery. Targeted drug delivery also allows the use of the primary non-metabolized synthesis, prior to first passage metabolism in the liver or systemically.
Do you have a drug that needs targeted delivery?
For further information about our drug delivery concept and IP, please contact us at 



Senaste nyheter